DD145740A5 - Verfahren zur herstellung eines synthetischen magnesiumaluminiumsilikats - Google Patents

Verfahren zur herstellung eines synthetischen magnesiumaluminiumsilikats Download PDF

Info

Publication number: DD145740A5
Authority: DD; German Democratic Republic
Prior art keywords: aqueous solution; calcium chloride; solution containing; product; aluminum silicate
Prior art date: 1978-09-07

Application number

DD79215388A

Other languages

German (de)

English (en)

Inventor

Adrian Schulthess

Jean-Claude Farine

Original Assignee

Om Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-09-07

Filing date

1979-09-06

Publication date

1981-01-07

1979-06-22 Priority claimed from CH589079A external-priority patent/CH639630A5/fr

1979-09-06 Application filed by Om Lab Sa filed Critical Om Lab Sa

1981-01-07 Publication of DD145740A5 publication Critical patent/DD145740A5/de

Links

238000004519 manufacturing process Methods 0.000 title claims abstract description 5
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title description 2
239000011777 magnesium Substances 0.000 title description 2
229910052749 magnesium Inorganic materials 0.000 title description 2
239000005995 Aluminium silicate Substances 0.000 title 1
PZZYQPZGQPZBDN-UHFFFAOYSA-N aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 title 1
229910000323 aluminium silicate Inorganic materials 0.000 title 1
235000012211 aluminium silicate Nutrition 0.000 title 1
238000002360 preparation method Methods 0.000 claims abstract description 15
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 12
239000007864 aqueous solution Substances 0.000 claims abstract description 10
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 8
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 8
238000003756 stirring Methods 0.000 claims abstract description 8
239000001110 calcium chloride Substances 0.000 claims abstract description 6
229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 6
238000005406 washing Methods 0.000 claims abstract description 5
229910018072 Al 2 O 3 Inorganic materials 0.000 claims abstract description 4
239000004115 Sodium Silicate Substances 0.000 claims abstract description 4
238000001914 filtration Methods 0.000 claims abstract description 4
229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 4
235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 4
239000002244 precipitate Substances 0.000 claims abstract description 4
NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims abstract description 4
229910052911 sodium silicate Inorganic materials 0.000 claims abstract description 4
239000008399 tap water Substances 0.000 claims abstract description 3
235000020679 tap water Nutrition 0.000 claims abstract description 3
238000000034 method Methods 0.000 claims description 10
229910004298 SiO 2 Inorganic materials 0.000 claims description 3
HZVVJJIYJKGMFL-UHFFFAOYSA-N almasilate Chemical compound O.[Mg+2].[Al+3].[Al+3].O[Si](O)=O.O[Si](O)=O HZVVJJIYJKGMFL-UHFFFAOYSA-N 0.000 claims description 2
BUACSMWVFUNQET-UHFFFAOYSA-H dialuminum;trisulfate;hydrate Chemical compound O.[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O BUACSMWVFUNQET-UHFFFAOYSA-H 0.000 claims description 2
238000001035 drying Methods 0.000 claims 1
SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 abstract description 15
230000002496 gastric effect Effects 0.000 abstract description 12
239000000243 solution Substances 0.000 abstract description 10
239000002253 acid Substances 0.000 abstract description 3
230000027455 binding Effects 0.000 abstract description 3
238000010521 absorption reaction Methods 0.000 abstract description 2
DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 abstract description 2
208000012895 Gastric disease Diseases 0.000 abstract 1
208000028774 intestinal disease Diseases 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000000047 product Substances 0.000 description 28
230000000694 effects Effects 0.000 description 13
239000000499 gel Substances 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
208000025865 Ulcer Diseases 0.000 description 9
239000000843 powder Substances 0.000 description 9
231100000397 ulcer Toxicity 0.000 description 9
239000000126 substance Substances 0.000 description 7
201000006549 dyspepsia Diseases 0.000 description 6
239000000203 mixture Substances 0.000 description 6
241000700159 Rattus Species 0.000 description 5
210000002784 stomach Anatomy 0.000 description 5
101000588924 Anthopleura elegantissima Delta-actitoxin-Ael1a Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
208000002193 Pain Diseases 0.000 description 4
208000024798 heartburn Diseases 0.000 description 4
230000000968 intestinal effect Effects 0.000 description 4
208000024981 pyrosis Diseases 0.000 description 4
229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
206010030216 Oesophagitis Diseases 0.000 description 3
125000003118 aryl group Chemical group 0.000 description 3
239000001768 carboxy methyl cellulose Substances 0.000 description 3
235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
239000008112 carboxymethyl-cellulose Substances 0.000 description 3
239000003814 drug Substances 0.000 description 3
238000006386 neutralization reaction Methods 0.000 description 3
239000008213 purified water Substances 0.000 description 3
238000012360 testing method Methods 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
208000007882 Gastritis Diseases 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000013065 commercial product Substances 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
208000006881 esophagitis Diseases 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000000855 fermentation Methods 0.000 description 2
230000004151 fermentation Effects 0.000 description 2
206010016766 flatulence Diseases 0.000 description 2
239000008103 glucose Substances 0.000 description 2
239000008187 granular material Substances 0.000 description 2
201000001421 hyperglycemia Diseases 0.000 description 2
-1 magnesium aluminum silicates Chemical class 0.000 description 2
238000002156 mixing Methods 0.000 description 2
230000007170 pathology Effects 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
230000035484 reaction time Effects 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
QYLJIYOGHRGUIH-CIUDSAMLSA-N Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N QYLJIYOGHRGUIH-CIUDSAMLSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
235000008733 Citrus aurantifolia Nutrition 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
FVIGODVHAVLZOO-UHFFFAOYSA-N Dixanthogen Chemical compound CCOC(=S)SSC(=S)OCC FVIGODVHAVLZOO-UHFFFAOYSA-N 0.000 description 1
206010020028 Hiatus hernia Diseases 0.000 description 1
235000008694 Humulus lupulus Nutrition 0.000 description 1
244000025221 Humulus lupulus Species 0.000 description 1
206010020601 Hyperchlorhydria Diseases 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
235000011941 Tilia x europaea Nutrition 0.000 description 1
238000002083 X-ray spectrum Methods 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000274 adsorptive effect Effects 0.000 description 1
GSWGDDYIUCWADU-UHFFFAOYSA-N aluminum magnesium oxygen(2-) Chemical compound [O--].[Mg++].[Al+3] GSWGDDYIUCWADU-UHFFFAOYSA-N 0.000 description 1
230000001458 anti-acid effect Effects 0.000 description 1
239000002518 antifoaming agent Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
150000001621 bismuth Chemical class 0.000 description 1
229910052797 bismuth Inorganic materials 0.000 description 1
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
238000009835 boiling Methods 0.000 description 1
238000001354 calcination Methods 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
231100000160 chronic toxicity Toxicity 0.000 description 1
230000007665 chronic toxicity Effects 0.000 description 1
230000003475 colitic effect Effects 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
239000004205 dimethyl polysiloxane Substances 0.000 description 1
229960001275 dimeticone Drugs 0.000 description 1
208000000718 duodenal ulcer Diseases 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000009472 formulation Methods 0.000 description 1
201000005917 gastric ulcer Diseases 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
239000012535 impurity Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000004571 lime Substances 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
235000014380 magnesium carbonate Nutrition 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
229910052625 palygorskite Inorganic materials 0.000 description 1
239000006069 physical mixture Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
239000011241 protective layer Substances 0.000 description 1
238000010992 reflux Methods 0.000 description 1
238000012453 sprague-dawley rat model Methods 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
231100000456 subacute toxicity Toxicity 0.000 description 1
239000000725 suspension Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
231100000041 toxicology testing Toxicity 0.000 description 1
238000010792 warming Methods 0.000 description 1
230000004580 weight loss Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/20—Silicates
- C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DD79215388A 1978-09-07 1979-09-06 Verfahren zur herstellung eines synthetischen magnesiumaluminiumsilikats DD145740A5 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH938478		1978-09-07
CH589079A CH639630A5 (en)	1979-06-22	1979-06-22	Synthetic magnesium aluminium silicate, process for its manufacture and pharmaceutical compositions comprising it

Publications (1)

Publication Number	Publication Date
DD145740A5 true DD145740A5 (de)	1981-01-07

Family

ID=25698589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD79215388A DD145740A5 (de)	1978-09-07	1979-09-06	Verfahren zur herstellung eines synthetischen magnesiumaluminiumsilikats

Country Status (13)

Country	Link
US (1)	US4339421A (pl)
AR (1)	AR221103A1 (pl)
DD (1)	DD145740A5 (pl)
DE (1)	DE2936078C2 (pl)
ES (1)	ES484103A1 (pl)
FR (1)	FR2435442A1 (pl)
GB (1)	GB2031395B (pl)
HU (1)	HU180034B (pl)
IT (1)	IT1198313B (pl)
PL (1)	PL117242B1 (pl)
PT (1)	PT70125A (pl)
RO (1)	RO78238A (pl)
YU (1)	YU41174B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL68311A0 (en) *	1982-04-29	1983-07-31	Scras	Modified clays,their preparation and pharmaceutical compositions containing them
GB8421603D0 (en) *	1984-08-24	1984-09-26	British Petroleum Co Plc	Synthetic smectites and stabilised pillared analogues
US4745092A (en) *	1987-04-27	1988-05-17	The Dow Chemical Company	Strengthened cordierite having minor amounts of calcia
FR2639148B1 (fr) *	1988-11-16	1991-08-02	Merlin Gerin	Declencheur magnetique a large plage de reglage du seuil de declenchement
GB9720061D0 (en)	1997-09-19	1997-11-19	Crosfield Joseph & Sons	Metal compounds as phosphate binders
US6358365B1 (en) *	1999-12-14	2002-03-19	Hercules Incorporated	Metal silicates, cellulose products, and processes thereof
US20070154603A1 (en) *	2005-12-30	2007-07-05	Withiam Michael C	Treatment of cooking oils and fats with sodium magnesium aluminosilicate materials
MY157620A (en)	2006-01-31	2016-06-30	Cytochroma Dev Inc	A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en)	2007-07-27	2007-09-05	Ineos Healthcare Ltd	Use
GB0720220D0 (en)	2007-10-16	2007-11-28	Ineos Healthcare Ltd	Compound
GB0913525D0 (en)	2009-08-03	2009-09-16	Ineos Healthcare Ltd	Method
GB201001779D0 (en)	2010-02-04	2010-03-24	Ineos Healthcare Ltd	Composition
US9119887B2 (en)	2010-09-16	2015-09-01	Mo-Sci Corporation	Low-density magnesium-aluminum-silicate (MAS) microparticles for radiotherapy and/or radioimaging
US9849200B2 (en)	2010-09-16	2017-12-26	Mo-Sci Corporation	Strontium phosphate microparticle for radiological imaging and therapy
US8865123B1 (en)	2010-09-16	2014-10-21	Mo-Sci Corporation	Strontium phosphate microparticle for radiological imaging and therapy
KR102802415B1 (ko) *	2018-02-02	2025-04-30	더블유.알. 그레이스 앤드 캄파니-콘.	중합체용 제산제
US12497300B2 (en) *	2022-11-11	2025-12-16	National Cheng Kung University	Artificial tanzanite and its manufacturing method

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2384563A (en) *	1940-03-21	1945-09-11	Charles H Burton	Magnesium silicates and process for making same
US2970889A (en) *	1956-09-26	1961-02-07	Fuji Chem Ind Co Ltd	Process for the manufacture of magnesium aluminosilicate for medical uses
US2990247A (en) *	1958-01-27	1961-06-27	Mallinckrodt Chemical Works	Aluminum compounds
FR1330121A (fr) *	1959-07-22	1963-06-21	Mallinckrodt Chemical Works	Perfectionnements apportés aux procédés de préparation de silicates doubles d'aluminium et de magnésium
FR53M (fr) *	1960-07-11	1961-01-09	Laboratoire A Castaigne	Applications thérapeutiques de l'arginase corps (45-25c)
GB925001A (en) *	1960-09-28	1963-05-01	Reckitt & Sons Ltd	Pharmaceutical compositions
US3032394A (en) *	1960-12-06	1962-05-01	Fuji Chem Ind Co Ltd	Process for manufacture of magnesium alumino-silicate
DE1667490B1 (de) *	1967-02-10	1971-07-01	Fuji Chem Ind Co Ltd	Verfahren zur herstellung von magnesium aluminiumsilicat fuer medizinische zwecke
FR1519706A (fr) *	1967-02-16	1968-04-05	Fuji Chem Ind Co Ltd	Procédé de préparation d'aluminosilicate de magnésium
FR6778M (pl) *	1967-07-10	1969-03-10
US3636200A (en) *	1969-06-09	1972-01-18	Hoffmann La Roche	Pharmaceutical suspension
US3767794A (en) *	1969-11-21	1973-10-23	Richardson Merrell Inc	Antifoam preparations and method of preparing same
JPS5510539B2 (pl) *	1972-05-22	1980-03-17
US4108984A (en) *	1977-01-14	1978-08-22	Masataro Sato	Compositions and methods for the treatment of athlete's foot
PL59294Y1 (en) *	1997-06-30	2002-08-30	Jerzy Boltromiuk	Central heating boiler

1979
- 1979-07-30 FR FR7919521A patent/FR2435442A1/fr active Granted
- 1979-08-13 IT IT25088/79A patent/IT1198313B/it active
- 1979-08-21 YU YU2047/79A patent/YU41174B/xx unknown
- 1979-08-24 US US06/069,542 patent/US4339421A/en not_active Expired - Lifetime
- 1979-08-27 PT PT70125A patent/PT70125A/pt unknown
- 1979-09-04 ES ES484103A patent/ES484103A1/es not_active Expired
- 1979-09-05 PL PL1979218133A patent/PL117242B1/pl unknown
- 1979-09-05 RO RO7998603A patent/RO78238A/ro unknown
- 1979-09-06 DE DE2936078A patent/DE2936078C2/de not_active Expired
- 1979-09-06 DD DD79215388A patent/DD145740A5/de not_active IP Right Cessation
- 1979-09-06 GB GB7930962A patent/GB2031395B/en not_active Expired
- 1979-09-07 HU HU79OA627A patent/HU180034B/hu not_active IP Right Cessation
- 1979-09-07 AR AR277990A patent/AR221103A1/es active

Also Published As

Publication number	Publication date
IT7925088A0 (it)	1979-08-13
HU180034B (en)	1983-01-28
FR2435442B1 (pl)	1983-07-29
ES484103A1 (es)	1980-04-16
AR221103A1 (es)	1980-12-30
GB2031395A (en)	1980-04-23
FR2435442A1 (fr)	1980-04-04
PL218133A1 (pl)	1980-06-02
PT70125A (fr)	1979-09-01
DE2936078C2 (de)	1982-03-11
DE2936078A1 (de)	1980-03-20
YU204779A (en)	1984-02-29
YU41174B (en)	1986-12-31
IT1198313B (it)	1988-12-21
US4339421A (en)	1982-07-13
RO78238A (ro)	1982-04-12
GB2031395B (en)	1982-10-13
PL117242B1 (en)	1981-07-31

Legal Events

Date	Code	Title	Description
1997-02-13	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
DE2936078C2 (de)	1982-03-11	Synthetisches Magnesiumaluminiumsilikat und dieses enthaltendes pharmazeutisches Präparat
DE3406127A1 (de)	1984-08-23	Diaet-faserprodukt
DE19745712A1 (de)	1999-04-22	Pflanzlicher Wirkstoff zur Behandlung der Sichelzellenanämie und Verfahren zu seiner Herstellung und Anwendung
DE69811137T2 (de)	2003-11-27	Flüssige Antazida, die Calciumcarbonat enthalten
DE69128760T2 (de)	1998-04-30	Antidiarrhoeika
DE3784695T2 (de)	1993-10-14	Gebrauch von Gramineenextrakten als Arzneimittel.
CH647409A5 (de)	1985-01-31	Pharmazeutische zubereitung zur behandlung und verhinderung von entzuendlichen darmkrankheiten, salze der 5,5'-azobissalicylsaeure und verfahren zur herstellung dieser salze.
CH642085A5 (de)	1984-03-30	Verfahren zur gewinnung der polaren fraktion mit antipsoriatischer wirksamkeit eines extraktes aus farnpflanzen sowie ein gemaess diesem verfahren hergestelltes praeparat.
DE2113215A1 (de)	1971-10-07	Therapeutisches Kompositum
DE69002611T2 (de)	1994-02-03	Flüssige, oral verabreichbare zusammensetzungen auf basis von essbaren ölen.
DE2317768C3 (de)	1979-06-21	Verfahren zur Herstellung eines antazid wirkenden Arzneimittels
EP0286781A2 (de)	1988-10-19	Pharmazeutische Zubereitung zur Behandlung von Erkrankungen des Magen-Darm-Traktes
DE69100053T2 (de)	1993-10-21	Arzneimittelzusammensetzung in stabiler wässriger Suspensionsform auf der Basis von Sucralfat und einem Antacidum sowie Verfahren zu ihrer Herstellung.
DE2342460A1 (de)	1974-03-07	Eisen- oder aluminiumglycyrrhizinat enthaltendes produkt, verfahren zu seiner herstellung und dieses produkt enthaltendes arzneimittel
DE1192635B (de)	1965-05-13	Verfahren zur Herstellung von Wismutpektinat
DE3315606C2 (pl)	1988-05-26
DE2047049C3 (de)	1980-09-04	Calciumsalz der 6-(N-Acetylamino)hexansSure, Verfahren zu seiner Herstellung und Arzneimittel mit einem Gehalt an diesem Salz
DE1043587B (de)	1958-11-13	Verfahren zur Herstellung eines Appetitzueglers
DE1936723C2 (de)	1983-12-22	Salze von Chinarindenalkoloiden und Verfahren zu ihrer Herstellung
DE2919291A1 (de)	1979-11-22	Die verwendung von silikagel zur senkung des fettspiegels im blut
DE2015877C3 (de)	1979-06-07	Arzneimittel zur Behandlung der Prostatahypertrophie
DE1617277C3 (de)	1979-10-31	Verfahren zur Herstellung eines flüssigen Antazidums
DE2659465C2 (de)	1983-11-24	Pflanzliche Wirkstoffextrakte aus Hypoxidaceen und ihre Anwendung
AT400302B (de)	1995-12-27	Pharmazeutische salbe mit einem gehalt an piroxicam und verfahren zur herstellung derselben
AT275556B (de)	1969-10-27	Verfahren zur Herstellung von neuem N-Methylglucosammoniumpolygalakturonat